{
    "clinical_study": {
        "@rank": "16515", 
        "acronym": "PREOXYFLOW", 
        "arm_group": [
            {
                "arm_group_label": "PREOXYFLOW", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized in \"PREOXYFLOW\" group will received a four minutes preoxygenation period with Nasal High Flow Therapy (HFT) Optiflow \u00ae (60 l/mn FIO2 = 1) before orotracheal intubation under laryngoscopy after crash induction"
            }, 
            {
                "arm_group_label": "STANDARD FACE MASK", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients randomized in \"STANDARD FACE MASK\" group will received a four minutes preoxygenation period with a standard face mask (15 l/mn) before orotracheal intubation under laryngoscopy after crash induction. No specific trademark is requested by the protocol."
            }
        ], 
        "brief_summary": {
            "textblock": "Oro-tracheal intubation in intensive unit care(ICU) in acute hypoxemic respiratory failure\n      after crash induction remains a critical event.\n\n      The aim of this study is to determine whether Nasal High Flow Therapy (HFT) Optiflow \u00ae is\n      more efficient than the face mask for preoxygenation before orotracheal intubation after\n      crash induction in acute hypoxemic respiratory failure"
        }, 
        "brief_title": "Benefits of Optiflow\u00ae Device for Preoxygenation Before Intubation in Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Hypoxemic Respiratory Failure", 
        "condition_browse": {
            "mesh_term": "Respiratory Insufficiency"
        }, 
        "detailed_description": {
            "textblock": "This study will be designed as followed : Patients will be randomized in 2 groups\n      :\"PREOXYFLOW\" or \"STANDARD FACE MASK\".\n\n      Patients randomized in \"PREOXYFLOW\" group will received a four minutes preoxygenation period\n      with Nasal High Flow Therapy (HFT) (60 l/mn FIO2 = 1) before orotracheal intubation under\n      laryngoscopy after crash induction. Patients randomized in \"STANDARD FACE MASK\" group will\n      received a four minutes preoxygenation period with standard face mask (15 l/mn) before\n      orotracheal intubation under laryngoscopy after crash induction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults older than 18 years regardless of the gender\n\n          -  Acute hypoxemic respiratory failure defined as :\n\n        Respiratory rate > 30/mn AND Hypoxemia with SpO2 <90% with oxygen supply > FiO2 0,5 AND\n        PaO2/FiO2 <300 mmHg\n\n        Exclusion Criteria:\n\n          -  Contraindication to oro-tracheal intubation\n\n          -  Intubation without anesthetic delivery\n\n          -  Intubation during cardiac arrest\n\n          -  Asphyxia with immediate intubation needed\n\n          -  Nasopharyngeal obstacle with contraindication to use Optiflow device\n\n          -  Patients with a documented Cormack IV exposition before inclusion\n\n          -  Protected adult\n\n          -  Pregnancy\n\n          -  Lack of consent\n\n          -  Patient already enrolled in an other randomized study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "122", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01747109", 
            "org_study_id": "RC12_0178"
        }, 
        "intervention": [
            {
                "arm_group_label": "PREOXYFLOW", 
                "description": "Patients randomized in \"PREOXYFLOW\" group will received a four minutes preoxygenation period with Nasal High Flow Therapy (HFT) Optiflow \u00ae (60 l/mn FIO2 = 1) before orotracheal intubation under laryngoscopy after crash induction", 
                "intervention_name": "PREOXYFLOW", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "STANDARD FACE MASK", 
                "description": "Patients randomized in \"STANDARD FACE MASK\" group will received a four minutes preoxygenation period with a standard face mask (15 l/mn) before orotracheal intubation under laryngoscopy after crash induction. Each hospital involved in this study will use the standard face mask as per its usual practice (no specific trademark requested by this protocol)", 
                "intervention_name": "STANDARD FACE MASK", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute hypoxemic respiratory failure", 
            "Preoxygenation", 
            "Crash induction"
        ], 
        "lastchanged_date": "December 9, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "state": "Loire Atlantique", 
                        "zip": "44093"
                    }, 
                    "name": "Nantes Universitary Hospital, medical intensive care unit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49933"
                    }, 
                    "name": "Angers Universitary Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }, 
                    "name": "Brest Universitary Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Roche/Yon", 
                        "country": "France", 
                        "zip": "85925"
                    }, 
                    "name": "La Roche/Yon Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Montpellier University hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Nantes Universitary Hospital, surgical intensive care unit"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multicenter, Randomized, Controlled, Parallel-group, Open Label Trial Evaluating Benefits of Nasal High Flow Therapy (HFT) in Preoxygenation Before Tracheal Intubation in Acute Hypoxemic Respiratory Failure", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "This outcome will be assessed from the beginning of the preoxygenation period to the end of orotracheal intubation by monitoring the pulse oxymetry", 
            "measure": "to determine whether Optiflow\u00ae  used during the preoxygenation period before orotracheal intubation after crash induction is more efficient than standard face mask.", 
            "safety_issue": "No", 
            "time_frame": "4 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01747109"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement of quality of preoxygenation", 
                "safety_issue": "No", 
                "time_frame": "4 minutes"
            }, 
            {
                "measure": "Reduction in side effects incidence related to  intubation", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "measure": "Reduction in Organ failure in the 5th day", 
                "safety_issue": "Yes", 
                "time_frame": "at day 5"
            }, 
            {
                "measure": "Reduction in morbi-mortality during the Intensive Care Unit stay.", 
                "safety_issue": "Yes", 
                "time_frame": "until day 28 OR, if patient still in the intensive care unit (ICU) at Day 28, until discharge of ICU"
            }
        ], 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}